Grants and Contributions:
Title:
Promoting ONETest Pathogenome at London Calling
Agreement Number:
927439
Agreement Value:
$0.00
Agreement Date:
Apr 25, 2019 - Jul 31, 2019
Description:
Fusion Genomics plans to introduce its ONETest Pathogenome, which will diagnose all known human pathogens, to the United Kingdom with the objective to close 1-2 pilot projects with KOL hospitals.
Organization:
National Research Council Canada
Expected Results:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Bruderheim, British Columbia, CA V5A 4W9
Reference Number:
172-2019-2020-Q1-927439
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
828602243
Recipient Type:
For-profit organization
Recipient's Legal Name:
Fusion Genomics Corp.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
CanExport
Program Purpose:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541710